Back to Journals » Patient Preference and Adherence » Volume 14

Adherence to Subcutaneous Anti-TNF Treatment in Chronic Inflammatory Rheumatism and Therapeutic Patient Education

Authors Fayet F, Fan A, Rodere M, Savel C, Pereira B, Soubrier M

Received 27 November 2019

Accepted for publication 28 January 2020

Published 24 February 2020 Volume 2020:14 Pages 363—369

DOI https://doi.org/10.2147/PPA.S240179

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Johnny Chen


Françoise Fayet,1 Angélique Fan,1 Malory Rodere,1 Carine Savel,1 Bruno Pereira,2 Martin Soubrier1

1Rheumatology Department, CHU Clermont-Ferrand, Clermont-Ferrand, France; 2Biostatistics Unit, CHU Clermont-Ferrand, Clermont-Ferrand, France

Correspondence: Françoise Fayet
Rheumatology Department, CHU Clermont-Ferrand, Place Henri Dunant, Clermont-Ferrand 63000, France
Email ffayet@chu-clermontferrand.fr

Objective: Poor patient adherence to anti-TNF treatment has proven to be a major roadblock to effective management. Therapeutic patient education (TPE) is now recognized as a crucial tool in managing conditions like chronic inflammatory rheumatism and in improving treatment adherence. This study aimed to assess whether different TPE programs might improve adherence to subcutaneous anti-tumor necrosis factor (anti-TNF) treatment in patients with rheumatoid arthritis (RA), ankylosing spondyloarthritis (AS), and psoriatic arthritis (PsA).
Methods: This was a retrospective, observational, monocentric study of current care practices. We included 193 patients (124 women; mean age 53.3 ± 14.8 years). All patients received subcutaneous anti-TNF treatment and one of three TPE models, delivered by a nurse, from 2009 to 2013. The cohort was grouped according to different educational models: M1: information (N=92); M2: individual TPE (N=80); and M3: individual and group TPE sessions (N=21). Adherence was assessed with the Morisky Medication Adherence Scale (MMAS-4™). Scores were rated as follows: good adherence (MMAS-4 = 4), moderate adherence (MMAS-4 = 2– 3), and poor adherence (MMAS-4 = 0– 1).
Results: The mean disease duration was 10 years [95% CI: 5 to 18]. The cohort comprised 113 patients with RA, 73 with AS, and seven with PsA. Overall, 146 (75.7%) patients displayed good adherence, 34 (17.6%) displayed moderate adherence, and 13 (6.7%) displayed poor adherence. The M3 group displayed less adherence than the M1 and M2 groups. Old age was the only factor correlated with good adherence (p=0.005). The level of knowledge had no significant impact on adherence.
Conclusion: This study demonstrated good adherence to anti-TNF treatment in patients that received TPE, particularly when it was delivered in individual sessions.

Keywords: chronic inflammatory rheumatism, subcutaneous anti-TNF, treatment adherence, therapeutic education


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]